Skip to main content

Table 3 Data to be collected at routine visits

From: Comparison of the influence of ticagrelor and clopidogrel on inflammatory biomarkers and vascular endothelial function for patients with ST-segment elevation myocardial infarction receiving emergency percutaneous coronary intervention: study protocol for a randomized controlled trial

 

Screening phase

Study phase

Evaluation

Screening

Follow-up

Time

−30 min

0

1 hour (after PCI)

24 hours (after PCI)

1 week (after PCI)

4 weeks (±3 days) (after PCI)

Visit number

V0

V1

V2

V3

V4

V5

Design

Inclusion/exclusion criteria

x

     

Informed consent

x

     

Demographics

x

     

Medical/surgical history, allergy history, alcohol habits, smoking habits

x

     

Symptom inquiry

x

x

x

x

x

x

Body weight

x

    

x

Physical examination

x

x

x

x

x

x

Vital signs: temperature/pulse/respiration/blood pressure

x

x

x

x

x

x

18-lead ECG

x

x

x

x

x

x

AE/SAE recording

x

x

x

x

x

x

Treatment adherence

x

x

x

x

x

x

Myocardial necrosis biomarkers

x

  

x

x

x

Laboratory testing/efficacy

CD40l/CRP/P-selectin/CECs

 

x

 

x

x

x

Laboratory testing/safety

Creatinine

 

x

 

x

x

x

Uric acid

   

x

x

x

AST/ALT/TBIL

   

x

x

x

Blood-routine

 

x

 

x

x

x

TG/TC/HDL-C/LDL-C

   

x

x

x

Serum Na+, K+, Cl−

 

x

 

x

x

x

Urinary albumin

   

x

 

x

Back to article page

Trials

ISSN: 1745-6215